Youlu Pan

776 total citations
38 papers, 609 citations indexed

About

Youlu Pan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Youlu Pan has authored 38 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Youlu Pan's work include Catalytic C–H Functionalization Methods (12 papers), Ubiquitin and proteasome pathways (7 papers) and Protein Degradation and Inhibitors (6 papers). Youlu Pan is often cited by papers focused on Catalytic C–H Functionalization Methods (12 papers), Ubiquitin and proteasome pathways (7 papers) and Protein Degradation and Inhibitors (6 papers). Youlu Pan collaborates with scholars based in China, Czechia and Pakistan. Youlu Pan's co-authors include Tahir Ali Chohan, Jian‐Zhong Chen, Hai‐Yan Qian, Wenhai Huang, Shenxin Zeng, Jianzhong Chen, Jiongjiong Chen, Zhengrong Shen, Haifeng Xu and Yanling Liu and has published in prestigious journals such as PLoS ONE, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Youlu Pan

34 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youlu Pan China 14 262 219 122 77 76 38 609
Hui-Yi Shiao Taiwan 12 271 1.0× 304 1.4× 114 0.9× 66 0.9× 65 0.9× 13 626
Cunlong Zhang China 17 379 1.4× 266 1.2× 132 1.1× 44 0.6× 67 0.9× 32 641
Xin Ku China 11 409 1.6× 262 1.2× 144 1.2× 66 0.9× 120 1.6× 25 722
Sung Yun Cho South Korea 15 356 1.4× 277 1.3× 115 0.9× 66 0.9× 29 0.4× 43 673
Xin Zhai China 16 369 1.4× 363 1.7× 153 1.3× 122 1.6× 41 0.5× 66 695
Zunhua Yang China 17 368 1.4× 348 1.6× 105 0.9× 98 1.3× 74 1.0× 58 762
Danny Hsu United States 12 214 0.8× 184 0.8× 117 1.0× 32 0.4× 31 0.4× 27 510
Yali Deng China 9 479 1.8× 236 1.1× 240 2.0× 77 1.0× 73 1.0× 13 802
Kai Yuan China 13 218 0.8× 168 0.8× 199 1.6× 91 1.2× 18 0.2× 36 603
Daniel H. O’Donovan United Kingdom 16 451 1.7× 301 1.4× 138 1.1× 36 0.5× 50 0.7× 27 833

Countries citing papers authored by Youlu Pan

Since Specialization
Citations

This map shows the geographic impact of Youlu Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youlu Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youlu Pan more than expected).

Fields of papers citing papers by Youlu Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youlu Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youlu Pan. The network helps show where Youlu Pan may publish in the future.

Co-authorship network of co-authors of Youlu Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Youlu Pan. A scholar is included among the top collaborators of Youlu Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youlu Pan. Youlu Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Zihan, et al.. (2025). A double-edged sword of neo-substrate degradation in PROTACs. European Journal of Medicinal Chemistry. 301. 118253–118253.
3.
Pan, Youlu, et al.. (2025). Fe-Catalyzed Hydrocyclization of Inactivated Alkenes to Synthesize Ring-Fused 2,3-Dihydroquinazolinone. The Journal of Organic Chemistry. 90(4). 1507–1513. 1 indexed citations
4.
Wang, Shu, et al.. (2024). Discovery of new non-covalent reversible BTK inhibitors: Synthesis, in silico studies, and in vitro evaluations. Chemico-Biological Interactions. 403. 111241–111241. 1 indexed citations
5.
Pan, Youlu, Peipei Wang, Jinxin Che, et al.. (2024). Discovery of N-Benzylpiperidinol derivatives as USP7 inhibitors against Hematology. Bioorganic Chemistry. 153. 107807–107807.
6.
Wu, Jianan, et al.. (2024). The progress of small molecules against cannabinoid 2 receptor (CB2R). Bioorganic Chemistry. 144. 107075–107075. 2 indexed citations
7.
Zeng, Shenxin, Ming Zeng, Jian‐Dong Huang, et al.. (2023). Discovery of potent and selective HPK1 inhibitors based on the 2,4-disubstituted pyrimidine scaffold with immune modulatory properties for ameliorating T cell exhaustion. Bioorganic Chemistry. 139. 106728–106728. 8 indexed citations
8.
Pan, Youlu, et al.. (2023). The progress of molecules and strategies for the treatment of HBV infection. Frontiers in Cellular and Infection Microbiology. 13. 1128807–1128807. 28 indexed citations
9.
Zeng, Shenxin, et al.. (2023). Current advances and development strategies of orally bioavailable PROTACs. European Journal of Medicinal Chemistry. 261. 115793–115793. 47 indexed citations
10.
Wei, Juying, et al.. (2023). A hybrid energy-based and AI-based screening approach for the discovery of novel inhibitors of JAK3. Frontiers in Medicine. 10. 1182227–1182227. 2 indexed citations
11.
Pan, Youlu, et al.. (2022). The progress of small-molecules and degraders against BCR-ABL for the treatment of CML. European Journal of Medicinal Chemistry. 238. 114442–114442. 20 indexed citations
12.
Pan, Youlu, et al.. (2022). The Synthesis of 5,6‐dihydrobenzo[4,5]imidazo[2,1‐a]isoquinoline Derivatives via Metal‐Free Radical Cascade Pathway. Advanced Synthesis & Catalysis. 364(17). 3043–3048. 5 indexed citations
13.
Shao, Jiaan, Shuangrong Liu, Xingyu Liu, Youlu Pan, & Wenteng Chen. (2020). Design, synthesis and SAR study of 2-aminopyrimidines with diverse Michael addition acceptors for chemically tuning the potency against EGFRL858R/T790M. Bioorganic & Medicinal Chemistry. 28(19). 115680–115680. 9 indexed citations
14.
Wang, Zhilong, et al.. (2018). Design, Synthesis, and SAR Studies of Heteroarylpyrimidines and Heteroaryltriazines as CB2R Ligands. ChemMedChem. 13(22). 2455–2463. 4 indexed citations
15.
Wang, Zhilong, et al.. (2017). Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies. European Journal of Medicinal Chemistry. 137. 598–611. 11 indexed citations
16.
Chohan, Tahir Ali, et al.. (2016). Molecular modeling studies to characterize N -phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations. Molecular BioSystems. 12(4). 1250–1268. 64 indexed citations
17.
Chohan, Tahir Ali, et al.. (2015). Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7. Molecular BioSystems. 12(1). 145–161. 50 indexed citations
19.
Chohan, Tahir Ali, Hai‐Yan Qian, Youlu Pan, & Jian‐Zhong Chen. (2014). Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents. Current Medicinal Chemistry. 22(2). 237–263. 153 indexed citations
20.
Ma, Zhen, Youlu Pan, Wenhai Huang, et al.. (2013). Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents. Bioorganic & Medicinal Chemistry Letters. 24(1). 220–223. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026